Scientific paper - Original scientific paper
Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients
Journal of Personalized Medicine, 14 (2024), 3; 278. https://doi.org/10.3390/jpm14030278

Vučinić, Damir; Skočilić, Iva; Golčić, Marin; Dobrila-Dintinjana, Renata; Kolak, Maja; Jerković, Ivona; Tesar, Eleonora Cini; Ferari, Ani Mihaljević; Ređović, Arnela; Marušić, Jasna; Kolovrat, Doris; Mikolašević, Ivana

Cite this document

Vučinić, D., Skočilić, I., Golčić, M., Dobrila Dintinjana, R., Kolak, M., Jerković, I. ... Mikolašević, I. (2024). Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients. Journal of Personalized Medicine, 14. (3). doi: 10.3390/jpm14030278

Vučinić, Damir, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients." Journal of Personalized Medicine, vol. 14, no. 3, 2024. https://doi.org/10.3390/jpm14030278

Vučinić, Damir, Iva Skočilić, Marin Golčić, Renata Dobrila Dintinjana, Maja Kolak, Ivona Jerković, Eleonora Cini Tesar, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients." Journal of Personalized Medicine 14, no. 3 (2024). https://doi.org/10.3390/jpm14030278

Vučinić, D., et al. (2024) 'Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients', Journal of Personalized Medicine, 14(3). doi: 10.3390/jpm14030278

Vučinić D, Skočilić I, Golčić M, Dobrila Dintinjana R, Kolak M, Jerković I, and sur.. Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients. Journal of Personalized Medicine [Internet]. 2024 March 01 [cited 2024 July 08];14(3). doi: 10.3390/jpm14030278

D. Vučinić, et al., "Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients", Journal of Personalized Medicine, vol. 14, no. 3, March 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:957807. [Accessed: 08 July 2024]

Please login to the repository to save this object to your list.